Biliary Cancer Completed Phase 1 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0038607 (Biliary Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00551096Gemcitabine/Capecitabine/ZD6474 in Advanced Solid TumorsTreatment
NCT00626158Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary CancersTreatment